Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-05T12:27:16.116Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization

Published online by Cambridge University Press:  25 March 2010

G. S. Turner ,
K. G. Nicholson ,
D. A. J. Tyrrell  and
F. Y. Aoki
G. S. Turner
Affiliation:
Blood Products Laboratory, National Blood Transfusion Service, Elstree, Hertfordshire, England
K. G. Nicholson
Affiliation:
The Medical Research Council, Division of Communicable Diseases, Clinical Research Centre, Harrow, Middlesex, HA1 3UJ, England
D. A. J. Tyrrell
Affiliation:
The Medical Research Council, Division of Communicable Diseases, Clinical Research Centre, Harrow, Middlesex, HA1 3UJ, England
F. Y. Aoki
Affiliation:
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The antibody responses of 194 volunteers were studied for up to 3 years after primary immunization with one, two or three doses of human diploid cell rabies vaccine, administered either in 0·1 ml volumes intradermally (i.d.) or as 1·0 ml intramuscularly (i.m.). Sero-conversion occurred in 95% of subjects after the first injection and in 100% after the second. The highest titres and most durable antibody responses were induced by three injections of vaccine.

Booster doses were administered either by the subcutaneous (s.c.) or i.d. route, after 6, 12 or 24 months to randomly grouped volunteers; these induced responses ≥ 5·0 i.u. per ml in 95% of subjects. The responses were rapid and were neither influenced by the primary regimen nor by the timing and route of the booster dose.

Antibody titres after i.d. immunization were only two-fold lower than those induced by the larger volume of vaccine. The findings suggest that the i.d. route is both effective and economic.

Type
Research Article
Information
Journal of Hygiene , Volume 89 , Issue 1 , August 1982 , pp. 101 - 110
Copyright
Copyright © Cambridge University Press 1982

References

REFERENCES

Ajjan, N., Soulebot, J. P., Triau, R.& Biron, G. (1980). Intradermal immunization with rabies vaccine. Journal of the American Medical Association 244, 2528–2531.CrossRefGoogle ScholarPubMed
Anderson, L. J., Sikes, R. K., Langkop, L. W., Mann, J. M., Smith, J. S., Winkler, W. G. & Deitch, M. W. (1980). Post-exposure trial of a human diploid cell strain rabies vaccine. Journal of Infectious Diseases 142, 133–138.CrossRefGoogle Scholar
Aoki, F. Y., Tyrrell, D. A. J., Hill, L. E. & Turner, G. S. (1975). Immunogenicity and acceptability of a human diploid cell culture rabies vaccine in volunteers. Lancet i, 660–662.CrossRefGoogle Scholar
Atanasiu, P. (1973). Quantitative assay and potency test of antirabies serum and immunoglobulin. In Laboratory Techniques in Rabies, 3rd ed. (ed. Kaplan, M. M. and Koprowski, H.). World Health Organization Monograph series, no. 23, pp. 314–318. Geneva: World Health Organization.Google Scholar
Bahmanyar, M., Fayaz, A., Nour-Salehi, S., Mohammadi, M. & Koprowski, H. (1976). Successful protection of humans exposed to rabies infection. Post-exposure treatment with the new human diploid cell rabies vaccine and rabies serum. Journal of the American Medical Association 236, 2751–2754.CrossRefGoogle Scholar
Boe, E. & Nyland, H. (1980). Guillain-Barre syndrome after vaccination with human diploid cell rabies vaccine. Scandinavian Journal of Infectious Diseases 12, 231–232.CrossRefGoogle ScholarPubMed
Cox, J. H. & Schneider, L. G. (1976). Prophylactic immunization of humans against rabies by intradermal inoculations of human diploid cell culture vaccine. Journal of Clinical Microbiology 3, 96–101.CrossRefGoogle ScholarPubMed
Furlong, J. & Lea, G. (1980). Rabies prophylaxis simplified. Lancet i, 1311.Google Scholar
Kleitman, W., Schottle, A., Klietmann, B. & Cox, I. (1981). In Cell culture rabies vaccines and their protective effect in man (ed. Kuwert, E. K., Wiktor, T. J. & Koprowski, H.), pp. 330–337. Geneva: International Green Cross.Google Scholar
Kuwert, E. K., Marcus, I. & Hoher, P. G. (1976). Neutralizing and complement-fixing antibody responses in pre- and post-exposure vaccinees to a rabies vaccine produced in human diploid cells. Journal of Biological Standardization 4, 244–262.CrossRefGoogle ScholarPubMed
Lorenz, R. J. & Bögel, K. (1973). Methods of calculation: the Spearman-Kärber method. In Laboratory Techniques in Rabies, 3rd ed. (ed. Kaplan, M. M. & Koprowski, H.), World Health Organization Monograph series no. 23, pp. 321–329. Geneva: World Health Organization.Google ScholarPubMed
Miller, A. & Nathanson, N. (1977). Rabies: Recent advances in pathogenesis and control. Neurology 6, 511–519.Google Scholar
Morbidity and Mortality Weekly Report (1977). Rabies in a laboratory worker, New York. 26, 183–184.Google Scholar
Morbidity and Mortality Weekly Report (1981 a . Use of human diploid cell vaccine for post-exposure rabies treatment, Canada. 30 (22), 266–267.Google Scholar
Morbidity and Mortality Weekly Report (1981 b). Supplementary statement on Rabies Vaccine and Serologic testing 30 (42). 535–536.Google Scholar
Nicholson, K. G. & Prestage, H. (1982). Enzyme linked immunosorbent assay: a rapid reproducible test for the measurement of rabies antibody. Journal of Medical Virology 9, 43–49.CrossRefGoogle ScholarPubMed
Nicholson, K. G., Turner, G. S. & Aoki, F. Y. (1978). Immunization with a human diploid cell strain of rabies virus vaccine. Two year results. Journal of Infections Diseases 137, 783–788.CrossRefGoogle ScholarPubMed
Nicholson, K. G. & Turner, G. S. (1978). Studies with human diploid cell strain rabies vaccine and human antirahies immunoglobulin in man. Developments in Biological Standardization 40, 115–120.Google ScholarPubMed
Nicholson, K. G., Cole, P. J., Turner, G. S. & Harrison, P. (1979). Immune responses of humans to a human diploid cell strain of rabies virus vaccine: Lymphocyte transformation. production of virus neutralizing antibody, and induction of interferon. Journal of Infectious Diseases 140. 176–182.CrossRefGoogle ScholarPubMed
Plotkin, S. A. & Wiktor, T. (1978). Rabies vaccination. Annual Reviews of Medicine 29, 583–591.CrossRefGoogle ScholarPubMed
Rosanoff, E. & Tint, H. (1979). Responses to human diploid cell rabies vaccine: neutralizing antibody responses of vaccinees receiving booster doses of human diploid cell rabies vaccine. American Journal of Epidemiology 110, 322–327.CrossRefGoogle ScholarPubMed
Seligman, E. B. (1973). The NIH test for potency. In Laboratory Techniques in Rabies, 3rd ed. (ed Kaplan, M. M. & Koprowski, H.). World Health Organization Monograph series no. 23, pp. 279–286. Geneva: World Health Organization.Google Scholar
Simona, R., Keller, H., Spengler, G., Gerber, H., Weiss, M. & Steck, F. (1979). Revakzination gegen Lyssa beim Menschen: Wirksamkeit verechiedener Boosterschemata. Schweizerische Medizinische Wochenschrift 109, 1702–1708.Google Scholar
Turner, G. S. (1977). An assessment of the current position of rabies vaccination in man. In Recent Advances in Clinical Virology (ed. Waterson, A. P.). pp. 79–92. London. Churchill Livingstone.Google Scholar
Turner, G. S., Aoki, F. Y., Nicholson, K. G.Tyrrell, D. A. J. & Hill, L. E. (1976). Human diploid cell strain rabies vaccine. Rapid prophylactic immunization of volunteers with small doses. Lancet i, 1379–1381.CrossRefGoogle Scholar
Wiktor, T. J. & Koprowski, H. (1965). Successful immunisation of primates with rabies vaccine prepared in human diploid cells. Proceedings of the Society for experimental Biology & Medicine 118, 1069–1073.CrossRefGoogle Scholar
World Health Organization Expert Committee on Rabies. Third Report (1957). World Health Organization Technical Report Series, no. 121.Google Scholar
World Health Organization Expert Committee on Rabies. Sixth Report (1973). World Health Organization Technical Report Series no. 523.Google Scholar
WHO/IABS (1978). Joint Symposium on the Standardization of rabies vaccines for human use produced in Tissue Culture (Rabies III) (ed. Hennessen, W. & Regamey, R. H.. Developments in Biological Standardization 40. pp. 29–34. 79–139. 159–168. Basel: S. Karger.Google Scholar